Cited by 966Bone Metabolism and DiseasesBone health and osteoporosis researchBone and Dental Protein Studies

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Poole, Kenneth E. S., Van Bezooijen, Rutger L., Loveridge, Nigel, Hamersma, Herman, Papapoulos, Socrates E., Löwik, Clemens W., Reeve, Jonathan·2005·The FASEB Journal

DOI 10.1096/fj.05-4221fje

Open this paper in CoChat — free account

Abstract

Osteocytes are the most abundant cells in bone and are ideally located to influence bone turnover through their syncytial relationship with surface bone cells. Osteocyte‐derived signals have remained largely enigmatic, but it was recently reported that human osteocytes secrete sclerostin, an inhibitor of bone formation. Absent sclerostin protein results in the high bone mass clinical disorder sclerosteosis. Here we report that within adult iliac bone, newly embedded osteocytes were negative for sclerostin staining but became positive at or after primary mineralization. The majority of mature osteocytes in mineralized cortical and cancellous bone was positive for sclerostin with diffuse staining along dendrites in the osteocyte canaliculi. These findings provide for the first time in vivo evidence to support the concept that osteocytes secrete sclerostin after they become embedded in a mineralized matrix to limit further bone formation by osteoblasts. Sclerostin did not appear to influence the formation of osteocytes. We propose that sclerostin production by osteocytes may regulate the linear extent of formation and the induction or maintenance of a lining cell phenotype on bone surfaces. In doing so, sclerostin may act as a key inhibitory signal governing skeletal microarchitecture.

Integrity signals

Registry

Crossref · 10.1096/fj.05-4221fje

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G., Sutherland, M. K., Geoghegan, J. C., Yu, C., Hayes, T., Skonier, J. E., Shpektor, D., Jonas, M., Kovacevich, B. R., Staehling‐Hampton, K., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,114
Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011
Self-citation
Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist
van Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L. J. A., de Wilt, E., Karperien, M., Hamersma, H. A., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 893
Self-citation
Loss of Osteocyte Integrity in Association with Microdamage and Bone Remodeling After Fatigue In Vivo
Verborgt, O., Gibson, G. J., & Schaffler, M. B. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.60 · Cited by 731
Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells
Dobnig, H., & Turner, R. T. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628403 · Cited by 614
Periosteum: biology, regulation, and response to osteoporosis therapies
Allen, M. R., Hock, J. M., & Burr, D. B. (2004) · Bone · doi:10.1016/j.bone.2004.07.014 · Cited by 449
The Death of Osteocytes via Apoptosis Accompanies Estrogen Withdrawal in Human Bone
Tomkinson, A., REEVE, J., Shaw, R. W., & Noble, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4200 · Cited by 417
Self-citation

Show all 34 references

Research works printed but not linked: 2

Warmington K., 2004, Sclerostin antagonism in adult rodents, via monoclonal antibody mediated blockade, increases bone mineral density and implicates sclerostin as a key regulator of bone mass during adulthood (Abstract), J. Back Musculoskeletal. Rehabil., 19, S56
10.1210/jc.82.9.3128 · DOI

Sorted by citations

Items 301–400 of 966

Rethinking Bone Disease in Kidney Disease
Damasiewicz, M. J., & Nickolas, T. L. (2018) · JBMR Plus · doi:10.1002/jbm4.10117 · Cited by 52
The Autophagy in Osteoimmonology: Self-Eating, Maintenance, and Beyond
Xiao, L., & Xiao, Y. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00490 · Cited by 53
Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse
Zhang, D., Hu, M., Chu, T. H., Lin, L., Wang, J., Li, X., Ke, H. Z., & Qin, Y. (2016) · Bone · doi:10.1016/j.bone.2016.02.005 · Cited by 50
Circulating levels of sclerostin are associated with cardiovascular mortality
Novo‐Rodríguez, C., García-Fontana, B., Castillo, J. D. D. L.-D., Andújar-Vera, F., Ávila-Rubio, V., García‐Fontana, C., Morales, S., Rozas-Moreno, P., & Muñoz‐Torres, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199504 · Cited by 48
A novel nonosteocytic regulatory mechanism of bone modeling
Ofer, L., Dean, M. N., Zaslansky, P., Kult, S., Shwartz, Y., Zaretsky, J., Griess-Fishheimer, S., Ornan, E. M., Zelzer, E., & Shahar, R. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000140 · Cited by 52
Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy
Bojanić, K., Bilić-Čurčić, I., Kuna, L., Kizivat, T., Smolić, R., Lučić, N. R., Kralik, K., Šerić, V., Ivanac, G., Tucak-Zorić, S., et al. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090287 · Cited by 49
Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength
Kamiya, N., Shuxian, L., Yamaguchi, R., Phipps, M. C., Aruwajoye, O. O., Adapala, N. S., Yuan, H., Kim, H. K. W., & Feng, J. Q. (2016) · Bone · doi:10.1016/j.bone.2016.07.002 · Cited by 49
The role of carbonic anhydrase in the pathogenesis of vascular calcification in humans
Adeva‐Andany, M. M., Fernández‐Fernández, C., Sánchez-Bello, R., Donapetry, C., & Martínez‐Rodríguez, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.012 · Cited by 48
Preosteocytes/Osteocytes Have the Potential to Dedifferentiate Becoming a Source of Osteoblasts
Torreggiani, E., Matthews, B. G., Pejda, S., Matić, I., Horowitz, M. C., Grčević, D., & Kalajzić, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075204 · Cited by 48
The fragile elderly hip: Mechanisms associated with age-related loss of strength and toughness
REEVE, J., & Loveridge, N. (2014) · Bone · doi:10.1016/j.bone.2013.12.034 · Cited by 50
Self-citation
Involvement of periostin–sclerostin–Wnt/β-catenin signaling pathway in the prevention of neurectomy-induced bone loss by naringin
Lv, J., Sun, X., Ma, J., Ma, X., Xing, G., Wang, Y., Sun, L., Wang, J., Li, F., & Li, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.152 · Cited by 47
Sclerostin expression in the subchondral bone of patients with knee osteoarthritis
Wu, L., Guo, H., Sun, K., Zhao, X. S., Ma, T., & Jin, Q. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2741 · Cited by 49
Animal models for glucocorticoid-induced postmenopausal osteoporosis: An updated review
Zhang, Z., Ren, H., Shen, G., Qiu, T., Liang, D., Yang, Z., Yao, Z., Tang, J., Jiang, X., & Wei, Q. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.045 · Cited by 48
Is There a Governing Role of Osteocytes in Bone Tissue Regeneration?
Cao, W., Helder, M. N., Bravenboer, N., Wu, G., Jin, J., Bruggenkate, C. M. T., Klein‐Nulend, J., & Schulten, E. A. J. M. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00610-6 · Cited by 49
Osteocyte mechanotransduction in orthodontic tooth movement
Seddiqi, H., Klein-Nulend, J., & Jin, J. (2023) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00826-2 · Cited by 46
Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications
Yang, C., Chang, Z.-F., Chau, Y., Chen, A., Yang, W.-C., Yang, A., & Lee, O. K. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv043 · Cited by 46
The Chinese skeleton: insights into microstructure that help to explain the epidemiology of fracture
Cong, E., & Walker, M. D. (2014) · Bone Research · doi:10.1038/boneres.2014.9 · Cited by 46
Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4
Lv, W., Guan, L., Zhang, Y., Yu, S., Cao, B., & Ji, Y. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1379-8 · Cited by 46
Understanding the development of intermuscular bones in teleost: status and future directions for aquaculture
Nie, C., Hilsdorf, A. W. S., Wan, S., & Gao, Z. (2019) · Reviews in Aquaculture · doi:10.1111/raq.12348 · Cited by 46
Osteocyte Messages from a Bony Tomb
Bonewald, L. F. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.008 · Cited by 45
Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis
Lewiecki, E. M., Shah, A. D., & Shoback, D. (2015) · International Journal of Women s Health · doi:10.2147/ijwh.s73244 · Cited by 46
Bone Physiology and Biology
Gasser, J. A., & Kneissel, M. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-56192-9_2 · Cited by 53
1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion
Wijenayaka, A. R., Yang, D., Prideaux, M., Ito, N., Kogawa, M., Anderson, P., Morris, H. A., Solomon, L. B., Loots, G. G., Findlay, D. M., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.021 · Cited by 45
SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development
van Bezooijen, R. L., DeRuiter, M. C., Vilain, N., Monteiro, R. M., Visser, A., van der Wee-Pals, L. J. A., van Munsteren, C. J., Hogendoorn, P. C. W., Aguet, M., Mummery, C. L., et al. (2006) · Developmental Dynamics · doi:10.1002/dvdy.21054 · Cited by 45
Self-citation
Bone biology and the pathogenesis of osteoporosis
Russell, R. G. G., Espina, B., & Hulley, P. A. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000229521.95384.7d · Cited by 44
Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing’s syndrome
Belaya, Z. E., Rozhinskaya, L. Y., Mel'nichenko, G. A., Solodovnikov, A. G., Dragunova, N. V., Iljin, A. V., Dzeranova, L. K., & Dedov, I. I. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2268-y · Cited by 45
Icariin Regulates the Bidirectional Differentiation of Bone Marrow Mesenchymal Stem Cells through Canonical Wnt Signaling Pathway
Huang, J., Bao, Y., Xiang, W., Jing, X., Guo, J., Yao, X., Wang, R., & Guo, F. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/8085325 · Cited by 44
Alternating Differentiation and Dedifferentiation between Mature Osteoblasts and Osteocytes
Sawa, N., Fujimoto, H., Sawa, Y., & Yamashita, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-50236-7 · Cited by 44
Transcriptional Regulation of Osteoclastogenesis: The Emerging Role of KLF2
Rolph, D. N., & Das, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00937 · Cited by 43
Signaling pathways affected by mutations causing osteogenesis imperfecta
Etich, J., Rehberg, M., Eckes, B., Sengle, G., Semler, O., & Zaucke, F. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109789 · Cited by 50
Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects
Yao, Y., Kauffmann, F., Maekawa, S., Sarment, L., Sugai, J. V., Schmiedeler, C., Doherty, E. J., Holdsworth, G., Kostenuik, P. J., & Giannobile, W. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-73026-y · Cited by 46
Hyperglycemia increases the expression levels of sclerostin in a reactive oxygen species- and tumor necrosis factor-alpha-dependent manner
Kang, J., Boonanantanasarn, K., Baek, K., Woo, K. M., Ryoo, H., Baek, J., & Kim, G.-S. (2015) · Journal of Periodontal & Implant Science · doi:10.5051/jpis.2015.45.3.101 · Cited by 43
Osteocyte Deficiency in Hip Fractures
Delgado‐Calle, J., Arozamena, J., García-Renedo, R. J., García‐Ibarbia, C., Pascual-Carra, M. A., González-Macías, J., & Riancho, J. A. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9522-0 · Cited by 43
Targeted nanomedicines for the treatment of bone disease and regeneration
Ordikhani, F., Zandi, N., Mazaheri, M., Luther, G. A., Ghovvati, M., Akbarzadeh, A., & Annabi, N. (2020) · Medicinal Research Reviews · doi:10.1002/med.21759 · Cited by 45
HDAC7 Inhibits Osteoclastogenesis by Reversing RANKL-Triggered β-Catenin Switch
Jin, Z., Wei, W., Dechow, P. C., & Wan, Y. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1302 · Cited by 44
Isolation and gene expression of haematopoietic-cell-free preparations of highly purified murine osteocytes
Chia, L. Y., Walsh, N. C., Martin, T. J., & Sims, N. A. (2015) · Bone · doi:10.1016/j.bone.2014.11.005 · Cited by 42
Effect of liver dysfunction on circulating sclerostin
Rhee, Y., Kim, W. J., Han, K. J., Lim, S. K., & Kim, S. H. (2014) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0524-z · Cited by 42
New Approaches to the Treatment of Osteoporosis
Silva, B. C. C., & Bilezikian, J. P. (2010) · Annual Review of Medicine · doi:10.1146/annurev-med-061709-145401 · Cited by 42
The “soft” side of the bone: unveiling its endocrine functions
Cappariello, A., Ponzetti, M., & Rucci, N. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0009 · Cited by 44
Osteocytogenesis: Roles of Physicochemical Factors, Collagen Cleavage, and Exogenous Molecules
Chen, X., Wang, L., Zhao, K., & Wang, H. (2018) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2017.0378 · Cited by 41
The Biological Enhancement of Spinal Fusion for Spinal Degenerative Disease
Makino, T., Tsukazaki, H., Ukon, Y., Tateiwa, D., Yoshikawa, H., & Kaito, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082430 · Cited by 44
Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study
Saadeldin, M. K., Elshaer, S. S., Emara, I. A., Maged, M., & Abdel‐Aziz, A. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206761 · Cited by 45
The Osteocyte Transcriptome Is Extensively Dysregulated in Mouse Models of Osteogenesis Imperfecta
Zimmerman, S. M., Dimori, M., Heard‐Lipsmeyer, M. E., & Morello, R. (2019) · JBMR Plus · doi:10.1002/jbm4.10171 · Cited by 41
Serum sclerostin in alcoholics: a pilot study
González-Reimers, E., Martín-González, C., de la Vega-Prieto, M. J., Pelazas-González, R., Fernández-Rodríguez, C., López-Prieto, J., Alvisa-Negrín, J., & Santolaria-Fernández, F. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags136 · Cited by 41
Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study
Glorieux, F. H., Langdahl, B. L., Chapurlat, R. D., de Beur, S. M. J., Sutton, V. R., Poole, K. E. S., Dahir, K. M., ORWOLL, E. S., Willie, B. M., Mikolajewicz, N., et al. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae112 · Cited by 41
Self-citation
Osteocyte function under compressive mechanical force
Takano‐Yamamoto, T. (2013) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2013.10.004 · Cited by 46
Osteocyte specific responses to soluble and mechanical stimuli in a stem cell derived culture model
Thompson, W. R., Uzer, G., Brobst, K. E., Xie, Z., Sen, B., Yen, S. S., Styner, M., & Rubin, J. E. (2015) · Scientific Reports · doi:10.1038/srep11049 · Cited by 43
A proteomic analysis of adult rat bone reveals the presence of cartilage/chondrocyte markers
Schreiweis, M. A., Butler, J. P., Kulkarni, N. H., Knierman, M. D., Higgs, R. E., Halladay, D., Onyia, J. E., & Hale, J. E. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21196 · Cited by 41
Bone remodeling: A review of the bone microenvironment perspective for fragility fracture (osteoporosis) of the hip
Fazzalari, N. L. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.08.003 · Cited by 41
Osteoblasts, Osteoclasts, and Osteocytes: Unveiling Their Intimate-Associated Responses to Applied Orthodontic Forces
Lerner, U. H. (2012) · Seminars in Orthodontics · doi:10.1053/j.sodo.2012.06.002 · Cited by 49
Connexin hemichannels with prostaglandin release in anabolic function of bone to mechanical loading
Zhao, D., Riquelme, M. A., Guda, T., Tu, C., Xu, H., Gu, S., & Jiang, J. X. (2022) · eLife · doi:10.7554/elife.74365 · Cited by 43
Physiological consequences of space flight, including abnormal bone metabolism, space radiation injury, and circadian clock dysregulation: Implications of melatonin use and regulation as a countermeasure
Hirayama, J., Hattori, A., Takahashi, A., Furusawa, Y., Tabuchi, Y., Shibata, M., Nagamatsu, A., Yano, S., Maruyama, Y., Matsubara, H., et al. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12834 · Cited by 41
Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis
Martin, T. J., Sims, N. A., & Ng, K. W. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0575-5 · Cited by 42
The Pathophysiology of Osteoporosis after Spinal Cord Injury
Shams, R., Drasites, K. P., Zaman, V., Matzelle, D. D., Shields, D. C., Garner, D. P., Sole, C. J., Haque, A., & Banik, N. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063057 · Cited by 43
New insights into the location and form of sclerostin
Hernández, P., Whitty, C., Wardale, R. J., & HENSON, F. M. D. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.079 · Cited by 40
Unraveling the molecular and immunological landscape: Exploring signaling pathways in osteoporosis
Amroodi, M. N., Maghsoudloo, M., Amiri, S., Mokhtari, K., Mohseni, P., Pourmarjani, A., Jamali, B., Khosroshahi, E. M., Asadi, S., Tabrizian, P., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116954 · Cited by 42
Selective Estrogen Receptor Modulator Inhibits Osteocyte Apoptosis during Abrupt Estrogen Withdrawal: Implications for Bone Quality Maintenance
Huber, C., Collishaw, S., Mosley, J. R., REEVE, J., & Noble, B. (2007) · Calcified Tissue International · doi:10.1007/s00223-007-9049-6 · Cited by 39
Self-citation
Metabolic Health and Disease: A Role of Osteokines?
Shimonty, A., Bonewald, L. F., & Huot, J. R. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01093-0 · Cited by 41
PTH receptor signalling, osteocytes and bone disease induced by diabetes mellitus
Marino, S., & Bellido, T. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01014-7 · Cited by 42
Sclerostin monoclonal antibody therapy with AMG 785: a potential treatment for osteoporosis
Lewiecki, E. M. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.540565 · Cited by 38
Recombinant sclerostin antagonizes effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size
Kogawa, M., Khalid, K. A., Wijenayaka, A. R., Ormsby, R. T., Evdokiou, A., Anderson, P., Findlay, D., & Atkins, G. J. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00175.2017 · Cited by 38
Sclerostin Directly Stimulates Osteocyte Synthesis of Fibroblast Growth Factor-23
Ito, N., Prideaux, M., Wijenayaka, A. R., Yang, D., Ormsby, R. T., Bonewald, L. F., & Atkins, G. J. (2021) · Calcified Tissue International · doi:10.1007/s00223-021-00823-6 · Cited by 38
Bone Structure, Development and Bone Biology
Khurana, J. S., & Safadi, F. F. (2009) · Springer eBooks · doi:10.1007/978-0-387-89845-2_1 · Cited by 41
Immunohistochemical evidence for sclerostin during cementogenesis in mice
Lehnen, S. D. M., Götz, W., Baxmann, M., & Jäger, A. (2012) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2012.02.014 · Cited by 38
Effects of low intensity vibration on bone and muscle in rats with spinal cord injury
Bramlett, H. M., Dietrich, W. D., Marcillo, A. E., Mawhinney, L. J., Furones-Alonso, O., Bregy, A., Peng, Y., Wu, Y., Pan, J., Wang, J., et al. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2748-8 · Cited by 38
Nuclear αNAC Influences Bone Matrix Mineralization and Osteoblast Maturation In Vivo
Meury, T., Akhouayri, O., Jafarov, T., Mandic, V., & St‐Arnaud, R. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00378-09 · Cited by 38
Changes in the spatial distribution of sclerostin in the osteocytic lacuno-canalicular system in alveolar bone due to orthodontic forces, as detected on multimodal confocal fluorescence imaging analyses
Nishiyama, Y., Matsumoto, T., Lee, J., Saitou, T., Imamura, T., Moriyama, K., Yamaguchi, A., & Iimura, T. (2014) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2014.08.013 · Cited by 38
Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis
Guañabens, N., Ruiz-Gaspà, S., Gifre, L., Miquel, R., Peris, P., Monegal, A., Dubrueil, M., Arias, A., & Parés, A. R. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2845 · Cited by 40
Parathyroid Hormone Induces Bone Cell Motility and Loss of Mature Osteocyte Phenotype through L-Calcium Channel Dependent and Independent Mechanisms
Prideaux, M., Dallas, S. L., Zhao, N., Johnsrud, E. D., Veno, P. A., Guo, D., Mishina, Y. M., Harris, S. E., & Bonewald, L. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125731 · Cited by 37
New horizons in osteoporosis therapies
Harsløf, T., & Langdahl, B. L. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.02.012 · Cited by 37
Bioglass/carbonate apatite/collagen composite scaffold dissolution products promote human osteoblast differentiation
Ferreira, S. A., Young, G. R., Jones, J. R., & Rankin, S. M. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111393 · Cited by 37
Synergistic use of biomaterials and licensed therapeutics to manipulate bone remodelling and promote non-union fracture repair
Simpson, C. R., Kelly, H. M., & Murphy, C. M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.011 · Cited by 38
The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives
Carvalho, C., Alves, C. M., & Frazão, J. M. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0339-9 · Cited by 36
Time-dependent effects of sclerostin antibody on a mouse fracture healing model.
Cui, L., Cheng, H., Song, C., Li, C., Simonet, W. S., Ke, H. Z., & Li, G. (2013) · PubMed · Cited by 36
Anabolic Agents and the Bone Morphogenetic Protein Pathway
Garrett, I. R. (2007) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)78004-8 · Cited by 35
Markers of Bone Metabolism Are Affected by Renal Function and Growth Hormone Therapy in Children with Chronic Kidney Disease
Doyon, A., Fischer, D., Bayazıt, A. K., Canpolat, N., Düzova, A., Sözeri, B., Bacchetta, J., Balat, A., Büscher, A. K., Candan, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0113482 · Cited by 35
An In Vitro Model for the Development of Mature Bone Containing an Osteocyte Network
Iordachescu, A., Amin, H. D., Rankin, S. M., Williams, R. L., Yapp, C., Bannerman, A., Pacureanu, A., Addison, O., Hulley, P. A., & Grover, L. M. (2017) · Advanced Biosystems · doi:10.1002/adbi.201700156 · Cited by 35
Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review
Shakeri, A., & Adanty, C. (2020) · Journal of Population Therapeutics & Clinical Pharmacology · doi:10.15586/jptcp.v27i1.655 · Cited by 35
The effect of parathyroid hormone on osteogenesis is mediated partly by osteolectin
Zhang, J., Cohen, A., Shen, B., Du, L., Tasdogan, A., Zhao, Z., Shane, E. J., & Morrison, S. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2026176118 · Cited by 35
Sclerostin: From Molecule to Clinical Biomarker
Omran, A. S., Atanasova, D., Landgren, F., & Magnusson, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094751 · Cited by 44
Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model
Perosky, J. E., Khoury, B. M., Jenks, T. N., Ward, F. S., Cortright, K., Meyer, B., Barton, D. K., Sinder, B. P., Marini, J. C., Caird, M. S., et al. (2016) · Bone · doi:10.1016/j.bone.2016.09.013 · Cited by 35
Cellular Processes by Which Osteoblasts and Osteocytes Control Bone Mineral Deposition and Maturation Revealed by Stage-Specific EphrinB2 Knockdown
Blank, M., & Sims, N. A. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00524-y · Cited by 35
Exploring the Interface between Inflammatory and Therapeutic Glucocorticoid Induced Bone and Muscle Loss
Webster, J. M., Fenton, C. G., LANGEN, R. C. J., & Hardy, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225768 · Cited by 36
Abnormal subchondral trabecular bone remodeling in knee osteoarthritis under the influence of knee alignment
Han, X., Cui, J., Chu, L., Zhang, W., Xie, K., Jiang, X., He, Z., Du, J., Ai, S., Sun, Q., et al. (2021) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2021.10.005 · Cited by 34
Wnt Pathway Extracellular Components and Their Essential Roles in Bone Homeostasis
Martínez‐Gil, N., Ugartondo, N., Grinberg, D., & Balcells, S. (2022) · Genes · doi:10.3390/genes13010138 · Cited by 31
Sclerostin: a possible target for the management of cancer-induced bone disease
Gkotzamanidou, M. A., Dimopoulos, M. A., Kastritis, E., Christoulas, D., Moulopoulos, L. A., & Terpos, E. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.697154 · Cited by 34
Novel insights on the effect of sclerostin on bone and other organs
Dreyer, T. J., Keen, J. A. C., Wells, L. M., & Roberts, S. J. (2023) · Journal of Endocrinology · doi:10.1530/joe-22-0209 · Cited by 36
Novel targets in bone and cartilage
Beyer, C., & Schett, G. A. (2010) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2010.03.001 · Cited by 33
Endochondral fracture healing with external fixation in the Sost knockout mouse results in earlier fibrocartilage callus removal and increased bone volume fraction and strength
Morse, A., Yu, N., Peacock, L., Mikulec, K., Krämer, I., Kneissel, M., McDonald, M. M., & Little, D. G. (2014) · Bone · doi:10.1016/j.bone.2014.10.018 · Cited by 34
Talking among Ourselves: Paracrine Control of Bone Formation within the Osteoblast Lineage
Tonna, S. J., & Sims, N. A. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9738-2 · Cited by 33
Early Response of Bone Marrow Osteoprogenitors to Skeletal Unloading and Sclerostin Antibody
Shahnazari, M., Wronski, T. J., Chu, V., Williams, A. A., Leeper, A. M., Stolina, M., Ke, H. Z., & Halloran, B. P. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9610-9 · Cited by 34
Sclerostin Antibody Augments the Anabolic Bone Formation Response in a Mouse Model of Mechanical Tibial Loading
Morse, A., Schindeler, A., McDonald, M. M., Kneissel, M., Krämer, I., & Little, D. G. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3330 · Cited by 32
DMP1 Ablation in the Rabbit Results in Mineralization Defects and Abnormalities in Haversian Canal/Osteon Microarchitecture
Liu, T., Wang, J., Xie, X., Wang, K., Sui, T., Liu, D., Lai, L., Zhao, H., Li, Z., & Feng, J. Q. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3683 · Cited by 33
Potential drug targets within bone morphogenetic protein signaling pathways
Gazzerro, E., & Minetti, C. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.01.003 · Cited by 33
Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers
Welldon, K. J., Findlay, D. M., Evdokiou, A., Ormsby, R. T., & Atkins, G. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.013 · Cited by 33
The function of immunomodulation and biomaterials for scaffold in the process of bone defect repair: A review
Dong, C., Tan, G., Zhang, G., Lin, W., & Wang, G. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1133995 · Cited by 34
Circulating Sclerostin Levels and Markers of Bone Turnover in Chinese-American and White Women
Costa, A. G., Walker, M. D., Zhang, C. A., Cremers, S., Dworakowski, E., McMahon, D. J., Liu, C., & Bilezikian, J. P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2106 · Cited by 32
Assembling Human Platelet Lysate into Multiscale 3D Scaffolds for Bone Tissue Engineering
Oliveira, S. M., Reis, R. L., & Mano, J. F. (2014) · ACS Biomaterials Science & Engineering · doi:10.1021/ab500006x · Cited by 33
Sclerostin expression is induced by BMPs in human Saos-2 osteosarcoma cells but not via direct effects on the sclerostin gene promoter or ECR5 element
Yu, L., van der Valk, M., Cao, J., Han, C.-Y. E., Juan, T., Bass, M., Deshpande, C., Damore, M. A., Stanton, R., & Babij, P. (2011) · Bone · doi:10.1016/j.bone.2011.08.016 · Cited by 33
Effect of aromatase inhibition on serum levels of sclerostin and dickkopf-1, bone turnover markers and bone mineral density in women with breast cancer
Kyvernitakis, I., Rachner, T. D., Urbschat, A., Hars, O., Hofbauer, L. C., & Hadji, P. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1726-z · Cited by 33

Authors: Poole, K. E. S., Van Bezooijen, R. L., Loveridge, N., Hamersma, H., Papapoulos, S. E., Löwik, C. W., & Reeve, J.
Affiliations: University of Cambridge (GB)
Department of Endocrinology and Metabolic Diseases Leiden University Medical Centre Leiden Netherlands
South Africa
Leiden University (NL)
ORCID: Poole, Kenneth E. S.
Loveridge, Nigel
Hamersma, Herman
Papapoulos, Socrates E.
Löwik, Clemens W.
Reeve, Jonathan
Venue: The FASEB Journal
Publisher: Wiley
Published: 2005-08-25
Volume: 19
Issue: 13
Pages: 1842-1844
ISSN: 0892-6638 (ISSN-L)
1530-6860
DOI: 10.1096/fj.05-4221fje
OpenAlex: W1970864109
Cited by: 965
References: 34
Citations by year: 2026: 21 · 2025: 28 · 2024: 32 · 2023: 39 · 2022: 38 · 2021: 45 · 2020: 74 · 2019: 63 · 2018: 55 · 2017: 53 · 2016: 66 · 2015: 67 · 2014: 55 · 2013: 62 · 2012: 63
FWCI: 10.29
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: The FASEB Journal (publishedVersion)
PubMed (publishedVersion)
Funders: Medical Research Council
National Osteoporosis Society
European Commission (LSHM‐CT‐2003‐503020)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
Keywords: sclerostin, osteocytes, bone formation inhibition, sclerosteosis, osteoblasts, bone mineralization, bone lining cells, bone turnover
MeSH terms: Aged, Alkaline Phosphatase, Antibodies, Monoclonal, Biopsy, Bone and Bones, Bone Development, Bone Diseases, Developmental, Bone Resorption, Cell Differentiation, Coloring Agents, Female, Genetic Markers, Humans, Image Processing, Computer-Assisted, Immunohistochemistry, Male, Microscopy, Fluorescence, Middle Aged, Models, Biological, Osteoblasts, Osteocytes, Osteogenesis, RNA, Messenger, Time Factors, Tolonium Chloride, Signal Transduction, Bone Remodeling, Bone Morphogenetic Proteins, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks